2021
DOI: 10.1016/j.xcrm.2021.100482
|View full text |Cite
|
Sign up to set email alerts
|

More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancer

Abstract: Microbes in the gut impact response, resistance, and toxicity to numerous cancer therapies, though mechanisms remain incompletely understood. Blake et al. provide further evidence that gut microbes promote toxicity to immune-agonistic antibodies, with opportunities to target these in cancer treatment. 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
(10 reference statements)
0
1
0
Order By: Relevance
“…Interestingly, toxicity observed with CD137 IAAs also appears to converge at the level of host MyD88 activation by gut microbiota, which results in a CD8+ T-cell-dependent liver damage and IFNγ driven systemic inflammation. Importantly, toxicity to IAA therapy was reduced in germ-free or antibiotictreated mice in this model without a deleterious impact on antitumor immunity, suggesting a potential roadmap for irAE modulation and prevention in the clinical setting [83,84].…”
Section: The Role Of Gut Microbes and Diet In Toxicitymentioning
confidence: 89%
“…Interestingly, toxicity observed with CD137 IAAs also appears to converge at the level of host MyD88 activation by gut microbiota, which results in a CD8+ T-cell-dependent liver damage and IFNγ driven systemic inflammation. Importantly, toxicity to IAA therapy was reduced in germ-free or antibiotictreated mice in this model without a deleterious impact on antitumor immunity, suggesting a potential roadmap for irAE modulation and prevention in the clinical setting [83,84].…”
Section: The Role Of Gut Microbes and Diet In Toxicitymentioning
confidence: 89%